These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 9076381)

  • 41. A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty.
    Grines CL; Schreiber TL; Savas V; Jones DE; Zidar FJ; Gangadharan V; Brodsky M; Levin R; Safian R; Puchrowicz-Ochocki S; Castellani MD; O'Neill WW
    J Am Coll Cardiol; 1996 May; 27(6):1381-6. PubMed ID: 8626947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Relationship between x-ray morphology of atherosclerotic plaques and incidence of the development of restenosis after transluminal balloon coronary angioplasty].
    Savchenko AP; Saed IR; Matchin IuG; Smirnov AA; Liakishev AA
    Vestn Rentgenol Radiol; 1994; (1):4-9. PubMed ID: 7975161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thrombin activation and late restenosis after percutaneous transluminal coronary angioplasty.
    Salvioni A; Galli S; Marenzi G; Lauri G; Perego GB; Assanelli E; Guazzi MD
    Am Heart J; 1998 Mar; 135(3):503-9. PubMed ID: 9506337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clopidogrel has no effect on D-dimer and thrombin-antithrombin III levels in patients with peripheral arterial disease undergoing peripheral percutaneous transluminal angioplasty.
    Cassar K; Bachoo P; Ford I; Greaves M; Brittenden J
    J Vasc Surg; 2005 Aug; 42(2):252-8. PubMed ID: 16102623
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Persistent thrombin generation during heparin therapy in patients with acute coronary syndromes.
    Merlini PA; Ardissino D; Bauer KA; Oltrona L; Pezzano A; Bottasso B; Rosenberg RD; Mannucci PM
    Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1325-30. PubMed ID: 9261263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ticlopidine and aspirin pretreatment reduces coagulation and platelet activation during coronary dilation procedures.
    Gregorini L; Marco J; Fajadet J; Bernies M; Cassagneau B; Brunel P; Bossi IM; Mannucci PM
    J Am Coll Cardiol; 1997 Jan; 29(1):13-20. PubMed ID: 8996289
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of recombinant hirudin (CGP 39,393/TMREVASC) in the prevention of restenosis after percutaneous transluminal coronary angioplasty. Rationale and design of the HELVETICA trial, a multicentre randomized double blind heparin controlled study.
    Herrman JP; Simon R; Umans VA; Peerboom PF; Keane D; Rijnierse JJ; Bach D; Kobi P; Kerry R; Close P
    Eur Heart J; 1995 Nov; 16 Suppl L():56-62. PubMed ID: 8869020
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients. Angiographic results from the CAPTURE trial.
    van den Brand M; Laarman GJ; Steg PG; De Scheerder I; Heyndrickx G; Beatt K; Kootstra J; Simoons ML
    Eur Heart J; 1999 Nov; 20(21):1572-8. PubMed ID: 10529325
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris: analysis of early and late results.
    Meyer J; Schmitz HJ; Kiesslich T; Erbel R; Krebs W; Schulz W; Bardos P; Minale C; Messmer BJ; Effert S
    Am Heart J; 1983 Nov; 106(5 Pt 1):973-80. PubMed ID: 6227226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Absence of a prothrombotic state in restenotic patients?
    Brack MJ; More RS; Pringle S; Gershlick AH
    Coron Artery Dis; 1994 Jun; 5(6):501-6. PubMed ID: 7952409
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tissue plasminogen activator in refractory unstable angina. A randomized double-blind placebo-controlled trial in patients with refractory unstable angina and subsequent angioplasty.
    van den Brand M; van Zijl A; Geuskens R; de Feyter PJ; Serruys PW; Simoons ML
    Eur Heart J; 1991 Nov; 12(11):1208-14. PubMed ID: 1782951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coagulation activation in patients undergoing directional coronary atherectomy.
    Lins M; Zurborn KH; Dau O; Nagel E; Muurling S; Herrmann G; Simon R
    Thromb Res; 1997 Jun; 86(6):433-41. PubMed ID: 9219323
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The importance of serum lipid level for restenosis following initial successful percutaneous transluminal coronary angioplasty in patients with unstable angina].
    Kishi K; Hiasa Y; Tanaka H; Tanimoto M; Kinoshita M; Shinohara A; Wada T; Aihara T
    J Cardiol; 1996 Aug; 28(2):79-84. PubMed ID: 8814525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.
    Dibra A; Mehilli J; Braun S; Hadamitzky M; Baum H; Dirschinger J; Schühlen H; Schömig A; Kastrati A
    Am Heart J; 2005 Aug; 150(2):344-50. PubMed ID: 16086941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study.
    Lancet; 1997 May; 349(9063):1429-35. PubMed ID: 9164316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemostatic and fibrinolytic activation is less following cutting balloon angioplasty of the coronary arteries.
    Namiki A; Toma H; Nakamura M; Matsuda K; Hara H; Hara H; Asahara T; Soumitsu Y; Kobayashi N; Yamaguchi T
    Jpn Heart J; 2004 May; 45(3):409-17. PubMed ID: 15240961
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis.
    Ishiwata S; Tukada T; Nakanishi S; Nishiyama S; Seki A
    Am Heart J; 1997 Apr; 133(4):387-92. PubMed ID: 9124158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes: potential mechanisms for heightened prothrombotic potential.
    Becker RC; Spencer FA; Li Y; Ball SP; Ma Y; Hurley T; Hebert J
    J Am Coll Cardiol; 1999 Oct; 34(4):1020-7. PubMed ID: 10520784
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical significance of early percutaneous coronary intervention in patients with Braunwald III-B type unstable angina pectoris].
    Nozaki K; Nakao K; Horiuchi K; Kasanuki H; Honda T
    J Cardiol; 2003 Jun; 41(6):263-70. PubMed ID: 12845880
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
    Salvioni A; Casilli F; Assanelli E; Grazi M; Marenzi G; Guazzi MD
    Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.